MedPage Today on MSN
First-in-class drug wins FDA approval for polycythemia vera
Rusfertide mimics hepcidin to target erythrocytosis in rare blood malignancy ...
The FDA has approved rusfertide (Mimrylo) for adult patients with polycythemia vera (PV). 1 ...
EHR-based case finding identified 21.5% of coded PV patients with hematocrit above the <45% target, enabling intervention ...
Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for men vs women. Treatment guidelines in PV currently recommend maintaining ...
Hematocrit is the percentage of red blood cells in a person‘s blood. A typical hematocrit range in adults is 36–54%. However, age, sex, and health conditions can influence hematocrit levels. Low red ...
Hematocrit is the percentage of red blood cells in the total blood volume. Red blood cells are vital to your health. Imagine them as the subway system of your blood. They transport oxygen and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results